Background illustration for clinical trials search

Paid Clinical Trials Athens

Discover 1,359 paid clinical trials in Athens, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

for
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma,
Location: Atlanta GA, Birmingham AL, Durham NC, Indianapolis IN,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07488676

Phase1, Phase2, Recruiting

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Atlanta GA, Charlotte NC, Winston-Salem NC,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT07096778

Phase2, Recruiting

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

for
Relapsed and/or Refractory Multiple Myeloma (RRMM)
Location: Atlanta GA, Columbus OH, New York NY, Houston TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07222761

Phase3, Recruiting

Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy

for
Advanced Lung Non-Small Cell Carcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06731270

Phase2, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: Atlanta GA, Wytheville VA, Nashville TN,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

for
Carcinoid Syndrome, Carcinoid, Carcinoid Tumor,
Location: Atlanta GA, Lexington KY, Charlottesville VA, Tampa FL,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT07087054

Phase3, Recruiting

A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial

for
Human Papillomavirus-Related Carcinoma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 9+

Code: NCT07104240

Recruiting

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

for
Previously Untreated Relapsed Refractory Acute Myeloid Leukemia
Location: Atlanta GA, Chapel Hill NC, Cincinnati OH, Columbus OH,
Sponsor: Beat AML, LLC

Sex: All

Age: 18+

Code: NCT03013998

Phase2, Phase3, Recruiting

ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

for
Triple Negative Breast Cancer
Location: Atlanta GA
Sponsor: ProDa BioTech, LLC

Sex: All

Age: 18+

Code: NCT06460298

Phase1, Phase2, Recruiting

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

for
Haematological Malignancy, Acute Myeloid Leukemia,
Location: Atlanta GA, Indianapolis IN, Bethesda MD,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT04068597

Phase1, Phase2, Recruiting

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: Atlanta GA, Birmingham AL, Columbus OH, St Louis MO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT04973605

Phase1, Phase2, Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Atlanta GA, Albany GA, Tifton GA, Savannah GA,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

for
Hearing Loss, Head and Neck Cancer
Location: Atlanta GA, Fairfax VA, Bethesda MD, Baltimore MD,
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)

Sex: All

Age: 18 - 70+

Code: NCT04915183

Phase2, Recruiting

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

for
Malignant Solid Neoplasm
Location: Atlanta GA, Greer SC, Spartanburg SC, Hendersonville NC,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642611

Phase3, Recruiting

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

for
Malignant Digestive System Neoplasm
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT03800693

Phase2, Recruiting

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Atlanta GA, Charlotte NC, Nashville TN, Durham NC,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06619561

Phase2, Recruiting

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for
Colorectal Neoplasms
Location: Atlanta GA, Pinehurst NC, Wytheville VA, Nashville TN,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT05253651

Phase3, Recruiting

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

for
Ewing Sarcoma, Colorectal Adenocarcinoma
Location: Atlanta GA, Nashville TN, Cincinnati OH,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 12 - 70+

Code: NCT03715933

Phase1, Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

for
Multiple Myeloma
Location: Atlanta GA, Winston-Salem NC, Chapel Hill NC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05137054

Phase1, Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed Multiple Myeloma, Refractory Multiple Myeloma
Location: Atlanta GA, Chapel Hill NC, Detroit MI, Grand Rapids MI,
Sponsor: Opna Bio LLC

Sex: All

Age: 18+

Code: NCT06433947

Phase1, Recruiting